{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:32:45Z","timestamp":1782883965043,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.026","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T19:43:08Z","timestamp":1454701388000},"page":"1081-1089","source":"Crossref","is-referenced-by-count":17,"title":["Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"Wen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.108.191259","article-title":"Heart disease and stroke statistics\u20142009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/01.WNL.0000152985.32732.EE","article-title":"Timing of TIAs preceding stroke: time window for prevention is very short","volume":"64","author":"Rothwell","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0020","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.300.2.709","article-title":"Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells","volume":"300","author":"Kim","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0021-9150(99)00480-3","article-title":"Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats","volume":"152","author":"Tani","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0049-3848(99)00109-7","article-title":"Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery","volume":"96","author":"Kohda","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3988\/jcn.2008.4.4.148","article-title":"Cilostazol reduces PAC-1 expression on platelets in ischemic stroke","volume":"4","author":"Lee","year":"2008","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0045","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1474-4422(10)70198-8","article-title":"Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial","volume":"9","author":"Shinohara","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000338247","article-title":"Effect of cilostazol in acute lacunar infarction based on pulsatility index of transcranial Doppler (ECLIPse): a multicenter, randomized, double-blind, placebo-controlled trial","volume":"69","author":"Han","year":"2013","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jval.2011.01.011","article-title":"Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2","volume":"14","author":"Hoaglin","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0060","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0065","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"Lumley","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0070","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0075","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\u201cAICLA\u201d controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0085","first-page":"279","article-title":"The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study","volume":"15","author":"Tohgi","year":"1984","journal-title":"Agents Actions Suppl"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0090","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.STR.16.3.406","article-title":"Persantine Aspirin Trial in cerebral ischemia. Part II: endpoint results","volume":"16","year":"1985","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1600-0404.1987.tb03596.x","article-title":"Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks","volume":"76","author":"Matias-Guiu","year":"1987","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0105","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","author":"Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0115","first-page":"6","article-title":"A prospective randomized controlled study on ticlopidine with aspirin for the prevention of ischemic cerebral stroke","volume":"3","author":"Yizhao","year":"2000","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0120","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.289.22.2947","article-title":"Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial","volume":"289","author":"Gorelick","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0125","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2169\/internalmedicine.42.793","article-title":"Ticlopidine alone versus ticlopidine plus aspirin for preventing recurrent stroke","volume":"42","author":"Ito","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0130","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.STR.0000063141.24491.50","article-title":"Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial","volume":"34","author":"Matias-Guiu","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0135","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1212\/01.WNL.0000113757.34662.AA","article-title":"Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study","volume":"62","author":"Culebras","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0145","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"Group","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000111498","article-title":"A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction","volume":"25","author":"Fukuuchi","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0155","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1474-4422(08)70094-2","article-title":"Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study","volume":"7","author":"Huang","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0160","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0165","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12264-009-6192-2","article-title":"Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke","volume":"25","author":"Guo","year":"2009","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0170","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/STROKEAHA.107.505131","article-title":"Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): a randomized, double-blind, aspirin-controlled trial","volume":"39","author":"Shinohara","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1747-4949.2010.00535.x","article-title":"Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial","volume":"6","author":"Hankey","year":"2011","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0180","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(11)60600-4","article-title":"Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial","volume":"377","author":"Bousser","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0185","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/STROKEAHA.110.609370","article-title":"Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis","volume":"42","author":"Kwon","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000327036","article-title":"Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial","volume":"32","author":"Lee","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1159\/000327035","article-title":"The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial","volume":"31","author":"Uchiyama","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0200","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000369610","article-title":"Final results of cilostazol-aspirin therapy against recurrent stroke with intracranial artery stenosis (CATHARSIS)","volume":"5","author":"Uchiyama","year":"2015","journal-title":"Cerebrovasc Dis Extra"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0210","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.01.022","article-title":"A comparative study of dual versus monoantiplatelet therapy in patients with acute large-artery atherosclerosis stroke","volume":"23","author":"Yi","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.114.014791","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-year outcomes","volume":"132","author":"Wang","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0220","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.108.790048","article-title":"Cardiovascular disease and risk factors in Asia: a selected review","volume":"118","author":"Ueshima","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0006-2952(99)00346-9","article-title":"Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity","volume":"59","author":"Sudo","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0230","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10016-005-0012-6","article-title":"Effects of cilostazol on human venous smooth muscle","volume":"19","author":"Becker","year":"2005","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0235","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.atherosclerosis.2003.08.017","article-title":"Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication","volume":"171","author":"Wang","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.026_bib0240","doi-asserted-by":"crossref","first-page":"e002259","DOI":"10.1161\/JAHA.115.002259","article-title":"Long-term antiplatelet mono- and dual therapies after ischemic stroke or transient ischemic attack: network meta-analysis","volume":"4","author":"Xie","year":"2015","journal-title":"J Am Heart Assoc"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T13:50:20Z","timestamp":1537019420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305716000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1052305716000471"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.01.026","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726137287.793538012","asserted-by":"object"}]},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}